Compare RPD & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RPD | STAA |
|---|---|---|
| Founded | 2000 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Ophthalmic Goods |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 780.5M | 867.9M |
| IPO Year | 2015 | 1995 |
| Metric | RPD | STAA |
|---|---|---|
| Price | $5.85 | $26.43 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 22 | 9 |
| Target Price | $15.05 | ★ $22.81 |
| AVG Volume (30 Days) | ★ 2.0M | 1.1M |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $685,083,000.00 | $239,442,000.00 |
| Revenue This Year | N/A | $30.82 |
| Revenue Next Year | $0.54 | $8.41 |
| P/E Ratio | $16.65 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.97 | $15.59 |
| 52 Week High | $27.10 | $30.81 |
| Indicator | RPD | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 47.68 | 68.40 |
| Support Level | $5.10 | $23.75 |
| Resistance Level | $6.09 | $27.52 |
| Average True Range (ATR) | 0.40 | 1.25 |
| MACD | 0.12 | 0.07 |
| Stochastic Oscillator | 51.74 | 83.38 |
Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.